EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead

Runping Liu, Yajing Li, Qi Zheng, Mingning Ding, Huiping Zhou, Xiaojiaoyang Li

Acta Pharmaceutica Sinica B · 2024-03 · 14 (3) · 1009-1029

DOI: 10.1016/j.apsb.2023.10.023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2024-03. Verfasst von Runping Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102400, China. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BLRD VA, NIDDK NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

DNA methylationDrug developmentEpigenetics regulationHistone acetylationHistone methylationLiver fibrosisNon-coding RNAmRNA methylation

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102400, China.
  • School of Life Sciences, Beijing University of Chinese Medicine, Beijing 102400, China.
  • Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA 22460, USA.

Förderung

  • BLRD VA
  • NIDDK NIH HHS
  • National Institutes of Health
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Liu, R., Li, Y., Zheng, Q., Ding, M., Zhou, H., & Li, X. (2024). Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead. Acta Pharmaceutica Sinica B, 14(3), 1009-1029. https://doi.org/10.1016/j.apsb.2023.10.023

Vancouver

Liu R, Li Y, Zheng Q, Ding M, Zhou H, Li X. Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead. Acta Pharmaceutica Sinica B. 2024;14(3):1009-1029. doi:10.1016/j.apsb.2023.10.023

BibTeX
@article{Liu2024,
  author = {Liu, Runping and Li, Yajing and Zheng, Qi and Ding, Mingning and Zhou, Huiping and Li, Xiaojiaoyang},
  title = {Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2024},
  volume = {14},
  number = {3},
  pages = {1009--1029},
  doi = {10.1016/j.apsb.2023.10.023}
}
Kostenlos starten →